A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform

A novel microfluidic device capable of maintaining functional thyroid carcinoma specimens ex vivo provides a new drug screening platform

Abstract Background Though the management of malignancies has improved vastly in recent years, many treatment options lack the desired efficacy and fail to adequately augment patient morbidity and mortality. It is increasingly clear that patient response to therapy is unique to each individual, nece...

Full description

Bibliographic Details
Main Authors: Andrew Riley, Victoria Green, Ramsah Cheah, Gordon McKenzie, Laszlo Karsai, James England, John Greenman
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Cancer
Subjects:
Thyroid gland
Microfluidics
Viability
De-differentiation
Radioiodine therapy
Online Access:http://link.springer.com/article/10.1186/s12885-019-5465-z

Internet

http://link.springer.com/article/10.1186/s12885-019-5465-z

Similar Items